Figure 2.
GW3965 blunted the hypertensive effect of Ang II, which was significantly different with the 0.3 and 3 μg kg−1 doses for changes in MAP (a) and SBP (b) and significant with 3 μg kg−1 for DBP (c). Heart rates in control and GW3965-treated rats were similar at the time of blood pressure measurement (d). Results are mean±s.e.m. *P<0.05 vs control.